The research report on the
epigenetics drugs and diagnostic technologies market provides detailed analysis
of the global market and helps in understanding the driving forces for the
growth of these technologies. The report also provides analysis of the drugs market
by the mechanism of its action namely, DNMT inhibitors and HDAC inhibitors. The
report also discusses the diagnostic technologies market by types which include
DNA methylation and ChIP (Chromatin Immunoprecipitation) technology. Market
size estimates and forecasts for the period 2010 to 2018 has been given for
each segment and sub-segment, in terms of USD million, using 2010 as the base
year.
The market has also been segmented
geographically into four regions namely North America, Europe, Asia-Pacific,
and Rest of the World (RoW). Market size and forecast has been provided for
each of these regions. A detailed qualitative analysis of the factors
responsible for driving and restraining the growth of the epigenetics market
and future opportunities are provided in the report.
To Read The Complete Report with TOC: http://www.marketresearchreports.biz/
Competitive landscape and end user
analysis for the product types is highlighted and the market players are
profiled with attributes such as company overview, financial overview, business
strategies, product portfolio and recent developments. Market shares of the key
players for 2011 are provided, and recommendations to accentuate market shares
and ensure sustainability are also put forward in this report. Key market
player profiles in this report include Celgene Corporation, Eisai
Pharmaceuticals, Pharmacyclics Inc., Merck & Co. Inc. and others.
The global epigenetics drugs and
diagnostic technologies market is segmented into the following categories:
- Epigenetics Drugs Market, by
Mechanism of Action
- DNMT Inhibitors
- Azacitidine (Vidaza)
- Decitabine (Dacogen
- HDAC Inhibitors
- Vorinostat (Zolinza
- Romidepsin (Istodax)
- Epigenetics Diagnostic
Technologies Market, by Types
- DNA Methylation
- Chromatin Immunoprecipitation
(ChIP) Technology
- Epigenetics Technologies
Market, by Geography
- North America
- Europe
- Asia-Pacific
Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948
No comments:
Post a Comment